$64.78
0%
Price vs. AI Score (Last 150 days)
Data gathered: December 4
Data gathered: December 4
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 1,700 0% |
|
| Sentiment | 94 0% |
|
| Webpage traffic | 728,000 11.6% |
|
| Customer reviews | N/A | N/A |
| Employee Rating | 82 0% |
|
| Google Adspend | $5,678 122.8% | N/A |
| Google Trends | 21 -48.8% |
|
| Linkedin Employees | 67,422 N/A |
|
| Lobbying Cost | $380,000 0% |
|
| NPS | 23 -4.2% |
|
| Patents | 0% |
|
| 4chan Mentions | 0% |
|
| Facebook Engagement | 105 -0.9% |
|
| Facebook followers | 57,760 0% |
|
| Stocktwits Mentions | 6 -14.3% |
|
| Stocktwits Subscribers | 18,279 0% |
|
| Twitter Followers | 303,209 -0% |
|
| Youtube Subscribers | 13,900 0% |
|
| Instagram Followers | 67,628 0% |
|
| News Mentions | 2 -87.5% |
|
| Reddit Mentions | 0% |
|
| Business outlook | 81 0% |
|
In the news
 |
AstraZeneca, AI biologics firm Absci tie up on cancer drug - FTDecember 2 - Yahoo |
 |
UPDATE 1-AstraZeneca, AI biologics firm Absci tie up on cancer drug - FTDecember 2 - Yahoo |
AstraZeneca ties up with AI biologics company to develop cancer drugDecember 2 - Yahoo |
|
 |
EU Investigate Potential Suicide Risk From New Class Of Weight-Loss DrugsDecember 1 - NDTV News |
Week In Review: Tang Capital Offers $465 Million For LianBio Plus 80% Of Any Licenses/DivestmentsDecember 1 - TalkMarkets |
|
 |
Regulators are looking into whether weight-loss drugs like Ozempic raise the risk of suicidal thoughtsDecember 1 - Fortune |
About Astrazeneca
AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.
| Price | $64.78 |
| Target Price | Sign up |
| Market Cap | $201B |
| Dividend Yield | 0.0224 |
| Industry | Drug Manufacturers |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$157.8 0% | 45 |
 |
Eli Lilly and CompanyLLY |
$584.35 0% | 58 |
 |
PfizerPFE |
$28.89 0% | 54 |
 |
AbbVieABBV |
$143.11 0% | 48 |
 |
TherapeuticsMDTXMD |
$2.73 0% | 37 |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 11.5B | 2.1B | 9.4B | 1.37B | 3.33B |
| Q2 '23 | 11.4B | 1.96B | 9.46B | 1.82B | 2.52B |
| Q1 '23 | 10.9B | 1.91B | 8.97B | 1.8B | 3.89B |
| Q4 '22 | 11.2B | 2.9B | 8.31B | 901M | 1.14B |
| Q3 '22 | 11B | 2.98B | 8B | 1.64B | 2.76B |
Read more about Astrazeneca and their earnings, price prediction, job posts, sentiment, webpage traffic, customer reviews, employee rating, google adspend, google trends, linkedin employees, lobbying cost, nps, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, instagram followers, news mentions, reddit mentions & business outlook.